Blood Clots And The Death Of Common Sense – OpEd
The author uses a media interview about an NFL player’s pulmonary embolism to argue that modern diagnostic tools have made doctors reluctant to rely on clinical judgment, leading to uncertainty about the significance of findings that would once have gone undetected.
Greater sensitivity of CT pulmonary angiography has increased PE diagnoses without a matching rise in mortality, raising concerns about overdiagnosis, incidental findings, unnecessary anticoagulation and a culture in which fear of missing disease or litigation drives testing over probability-based reasoning.
The essay calls for restoring thoughtful judgment—knowing when to investigate and when further testing will not help—while using algorithms and technology as aids rather than substitutes, so that medicine prioritizes patient benefit over the pursuit of absolute certainty.
A couple of days ago I was on national TV being asked the usual round of questions about an NFL player who’d apparently developed blood clots. How can a young, fit athlete get a pulmonary embolism (PE)? What are the symptoms? Can you fly with a clot? Could it have been picked up earlier?
All perfectly sensible questions, especially for a young athlete, who faces far more scrutiny than an ordinary patient would. Within the hour, the story was all over TV station websites. . Obviously, he’s got the country’s attention.
I’ve spent much of my career answering requests like this type. After doing emergency, pulmonary, and critical care for so long, you’d think you’d know everything about thromboembolic disease by now, and I really don’t find anything too surprising in that field anymore. I’ve seen PE kill patients who were absolutely stable just minutes before. I’ve also seen patients who were absolutely convinced they had a nasty clot, despite their presentation being very different. Both experiences have shaped how I think about the disease and reinforced that medicine needs the human element, something no machine, test, or algorithm can ever provide: Judgment.
The more I thought about that interview, the more I realized it wasn’t really about a footballer or pulmonary embolism. It was an interview about where modern medicine has gone. We have such wonderful diagnostic tools now, and at the same time we have created a situation where doctors are increasingly unwilling to use their own clinical judgment without some form of technological validation.
We can now pick up abnormalities that would have been completely invisible a generation ago, yet we can find ourselves in a position where we’re not sure whether that abnormality is of any significance. We’re absolutely superb at detecting disease, and we’re surprised by how uncertain we can be about when to stop looking.
At one time, a doctor’s most important tool was his own mind. That’s still true today, though I’m not sure we believe it anymore.
An Old Problem with a Modern Twist
About 180 years ago, Virchow examined the mechanisms of thrombosis and pulmonary arterial obstruction. His 1846 work and the papers collected in 1856 formed the pathological basis of what we now call thromboembolic disease [1,2]. Every medical student has heard of him at some stage, invariably in the context of the classic triad of venous stasis, endothelial injury, and hypercoagulability. The triad as we know it wasn’t actually Virchow’s. Historians have examined how later interpretations and reassemblies of his original observations produced the concept that now bears his name [3].
The historical detail is of course interesting, but the real issue is the physiology. Clots form because the biological milieu is pro-thrombotic. Flow may be slow. The vascular endothelium may be damaged or activated. The coagulation system may shift to a pro-thrombotic state. All of these can happen in isolation or in combination, and their relative importance varies from patient to patient.
A post op patient who is bedbound is not in the same physiological situation as a young athlete who has had an injury. A patient with active cancer is not in the same situation as a patient who has simply spent several hours sitting on an aircraft. They may all go on to have a venous thromboembolism (VTE), but the circumstances in which it occurs and the risks involved will be very different.
That’s why you can’t just see a symptom and order a test. You have to understand the patient, the patient’s situation, and the biology behind it. A swollen leg could be venous thrombosis, chronic venous insufficiency, a drug effect, trauma, inflammation, or a hundred other things. Shortness of breath could be a pulmonary embolism; it could be cardiac disease, it could be a pulmonary infection, it could be obstructive airways, it could be anemia, or it could be anxiety. The presence of a symptom is the first thing you consider in the diagnostic process; it is not the final one.
Virchow had no CT scanner, no D-dimer, no modern ultrasound. His was by no means a golden age of medical care. I wouldn’t trade the toolkit we have today for what was available in the 19th century. One thing to keep in mind, though, is the intellectual underpinning of his work. He looked at disease through the lens of observation, physiology, and pathology. All the modern technology we’ve developed has enormously improved our ability to look at the human body, but it hasn’t taken away the need to understand what we’re looking at.
A doctor who can order a test perfectly well but has absolutely no idea why he’s ordering it has missed a fundamental aspect of the job.
The Pulmonary Embolism We Must Not Miss
In 1998, Robert Fromm and I published a very brief paper in the Journal of Emergency Medicine called ‘Syncope: The Forgotten Sign of Pulmonary Embolism’ [4]. We drew attention to a sign that is easily overlooked when assessing a patient who has had a syncopal episode. Most of the time, syncope is not due to PE, but in a small number of cases it can be the initial presentation of a significant obstruction of the pulmonary circulation. Failure to appreciate that possibility can be very dangerous.
I still think we were absolutely right at the time. PE can present in all sorts of ways, and you have to watch for the possibility that a fairly common presentation could be a manifestation of a very serious underlying problem. Anyone who has managed a patient with massive PE will understand what I mean. A large PE can result in acute right ventricular failure, profound hypotension, circulatory collapse, and death. In some situations, minutes really do count, and you simply can’t afford to be slow.
We certainly didn’t suggest that every patient who fainted should have a pulmonary CT angiogram. That would misrepresent the clinical situation. The point is to identify which patients’ presentations are concerning. A fit young adult having a classic vasovagal episode after standing for a long time is a very different proposition to a post op patient who suddenly goes off the rails and falters at the same time as developing unexplained hypoxemia and tachycardia. Both can cause syncope, but the probability of PE differs vastly.
This distinction may seem fundamental, but it’s becoming increasingly important in an age where diagnostic technology can lead clinicians to simply order the test rather than engage in the appropriate reasoning first. We’re frequently in the position of wanting to investigate every single possibility just because we can. The result is not necessarily better medicine. It may be more expensive, more complex, and in some cases, actually worse medicine.
We all have to live with a rather uncomfortable reality as doctors. We will never catch every disease in every patient on the first go. No diagnostic system can be that precise. The aim of clinical medicine is to detect significant disease with enough accuracy to improve outcomes, and to do so without intervention when the potential harm outweighs the potential benefit. That, in itself, requires an appreciation of probability, and it seems to me that appreciation is now less in vogue than the pursuit of absolute certainty.
When a Diagnostic Test Becomes a Screening Test
In 2019, my colleagues and I published an editorial in Current Respiratory Medicine Reviews asking whether computed tomography with angiography (CTA) in PE was used as a diagnostic test or had, in fact, become a screening test [5]. The distinction is more significant than it initially appears.
CT pulmonary angiography is one of modern medicine’s great advances. It has completely transformed how we approach suspected pulmonary embolism, allowing us to rapidly and in great detail visualize the pulmonary arterial circulation. In the right clinical situation, it can provide information that directly affects management and can, in fact, save lives. I’ve used it throughout my career and have no desire to go........
